Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
Trial ID or NCT#
NCT01529437
Status
NOT RECRUITING
Purpose
This is a study for children and adults who are interested in a new therapy for their allergies to dust mite and timothy grass. The new therapy is called sublingual immunotherapy and the investigators are testing if it is safe and well tolerated.
Official Title
Phase 1 Single Center, Randomized, Controlled Study Using Sublingual Immunotherapy for Timothy Grass and Dust Mite Allergies
Eligibility Criteria
Ages Eligible for Study: Older than 5 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Kari Nadeau, MD, PhD
Contact us to find out if this trial is right for you.
Contact
Tessa Hunter
6507259142
View on ClinicalTrials.gov